Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Vaccination Rates in Patients With Medical Indications for the Pneumococcal Polysaccharide Vaccine in a Family Medicine Clinic.

Trovato A, Gunning K, Pippitt K.

J Pharm Pract. 2019 Apr;32(2):154-157. doi: 10.1177/0897190017745411. Epub 2017 Dec 10.

PMID:
29226755
2.

Uptake of pneumococcal polysaccharide vaccination among working-age adults with underlying medical conditions, United States, 2009.

Lu PJ, Nuorti JP.

Am J Epidemiol. 2012 Apr 15;175(8):827-37. doi: 10.1093/aje/kwr376. Epub 2012 Mar 8.

PMID:
22403807
3.

Pneumococcal vaccination in the emergency department: an assessment of need.

Rudis MI, Stone SC, Goad JA, Lee VW, Chitchyan A, Newton KI.

Ann Emerg Med. 2004 Oct;44(4):386-92.

PMID:
15459621
4.

A case series evaluating the serological response of adult asthma patients to the 23-valent pneumococcal polysaccharide vaccine.

Laratta CR, Williams K, Vethanayagam D, Ulanova M, Vliagoftis H.

Allergy Asthma Clin Immunol. 2017 Jun 7;13:27. doi: 10.1186/s13223-017-0200-2. eCollection 2017.

5.
7.

Beliefs, attitudes, and activities of healthcare personnel about influenza and pneumococcal vaccines.

Çiftci F, Şen E, Demir N, Çiftci O, Erol S, Kayacan O.

Hum Vaccin Immunother. 2018 Jan 2;14(1):111-117. doi: 10.1080/21645515.2017.1387703. Epub 2017 Nov 29.

8.

Evidence Brief: The Quality of Care Provided by Advanced Practice Nurses.

McCleery E, Christensen V, Peterson K, Humphrey L, Helfand M.

VA Evidence Synthesis Program Evidence Briefs [Internet]. Washington (DC): Department of Veterans Affairs (US); 2011-.
2014 Sep.

9.

Human Papillomavirus Vaccination: What Are the Reasons for Nonvaccination Among U.S. Adolescents?

Thompson EL, Rosen BL, Vamos CA, Kadono M, Daley EM.

J Adolesc Health. 2017 Sep;61(3):288-293. doi: 10.1016/j.jadohealth.2017.05.015.

PMID:
28842066
10.

A virtual clinic improves pneumococcal vaccination coverage among patients living with HIV at a Veterans Affairs Medical Center.

Burns CM, Banks RE, Wilson BM, Carter RR, Jump RLP, Perez F.

AIDS Care. 2018 Feb;30(2):146-149. doi: 10.1080/09540121.2017.1390542. Epub 2017 Oct 20.

11.

Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older.

Jackson LA, Gurtman A, van Cleeff M, Frenck RW, Treanor J, Jansen KU, Scott DA, Emini EA, Gruber WC, Schmoele-Thoma B.

Vaccine. 2013 Aug 2;31(35):3594-602. doi: 10.1016/j.vaccine.2013.04.084. Epub 2013 May 18.

12.

Influenza and pneumococcal vaccination of adults aged > or = 65: racial/ethnic differences.

Singleton JA, Santibanez TA, Wortley PM.

Am J Prev Med. 2005 Dec;29(5):412-20.

PMID:
16376704
13.

Determinants of adult vaccination at inner-city health centers: a descriptive study.

Nowalk MP, Zimmerman RK, Tabbarah M, Raymund M, Jewell IK.

BMC Fam Pract. 2006 Jan 10;7:2.

14.

Adults with invasive pneumococcal disease: missed opportunities for vaccination.

Kyaw MH, Greene CM, Schaffner W, Ray SM, Shapiro M, Barrett NL, Gershman K, Craig AS, Roberson A, Zell ER, Schuchat A, Bennett NM, Whitney CG; Active Bacterial Core Surveillance Program of the Emerging Infections Program Network.

Am J Prev Med. 2006 Oct;31(4):286-92. Epub 2006 Aug 22.

PMID:
16979452
15.

Pharmacists as providers: targeting pneumococcal vaccinations to high risk populations.

Taitel M, Cohen E, Duncan I, Pegus C.

Vaccine. 2011 Oct 19;29(45):8073-6. doi: 10.1016/j.vaccine.2011.08.051. Epub 2011 Aug 22.

16.

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.

Jackson LA, Gurtman A, Rice K, Pauksens K, Greenberg RN, Jones TR, Scott DA, Emini EA, Gruber WC, Schmoele-Thoma B.

Vaccine. 2013 Aug 2;31(35):3585-93. doi: 10.1016/j.vaccine.2013.05.010. Epub 2013 May 18.

17.

Surveillance of Vaccination Coverage Among Adult Populations - United States, 2014.

Williams WW, Lu PJ, O'Halloran A, Kim DK, Grohskopf LA, Pilishvili T, Skoff TH, Nelson NP, Harpaz R, Markowitz LE, Rodriguez-Lainz A, Bridges CB; Centers for Disease Control and Prevention (CDC).

MMWR Surveill Summ. 2016 Feb 5;65(1):1-36. doi: 10.15585/mmwr.ss6501a1.

PMID:
26844596
18.

Surveillance of Vaccination Coverage among Adult Populations - United States, 2015.

Williams WW, Lu PJ, O'Halloran A, Kim DK, Grohskopf LA, Pilishvili T, Skoff TH, Nelson NP, Harpaz R, Markowitz LE, Rodriguez-Lainz A, Fiebelkorn AP.

MMWR Surveill Summ. 2017 May 5;66(11):1-28. doi: 10.15585/mmwr.ss6611a1.

19.

Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23).

Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices.

MMWR Morb Mortal Wkly Rep. 2010 Sep 3;59(34):1102-6.

20.

13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study.

De Montalembert M, Abboud MR, Fiquet A, Inati A, Lebensburger JD, Kaddah N, Mokhtar G, Piga A, Halasa N, Inusa B, Rees DC, Heath PT, Telfer P, Driscoll C, Al Hajjar S, Tozzi A, Jiang Q, Emini EA, Gruber WC, Gurtman A, Scott DA.

Pediatr Blood Cancer. 2015 Aug;62(8):1427-36. doi: 10.1002/pbc.25502. Epub 2015 Mar 23. Erratum in: Pediatr Blood Cancer. 2019 Feb;66(2):e27554.

PMID:
25810327

Supplemental Content

Support Center